EPA triggers EVP Policy in response to recent Ebola outbreak in Uganda

October 26, 2022

On October 12, 2022, EPA triggered its Emerging Viral Pathogen Policy for the Ebola virus. This came in response to the CDC’s travel alert following an Ebola outbreak in Uganda.


According to the CDC, Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe infectious disease illness caused by 4 different viruses: Zaire ebolavirus, Bundibugyo ebolavirus, Tai Forest ebolavirus and Sudan ebolavirus.

Ebola virus is animal-borne (zoonotic) pathogen. Ebola is not airborne but is instead introduced into the human population through close contact with infected body fluids and contaminated surfaces.

Ebola outbreak triggers EVP Policy

Due to the outbreak, EPA released an updated list of disinfectants for emerging viral pathogens meaning products with an approved EVP claim can be used against the Ebola virus.

EPA categorizes viruses based on their difficulty to kill. Ebola is considered a Tier I virus and thereby easiest to kill. Because Ebola is a Tier I virus and the easiest to kill, disinfectants approved for Tier II and Tier III viruses can also be used against Ebola.

Products effective against Ebola virus can be found on EPA’s List-L. Additionally, EPA also references List-Q as a resource, as products registered on List-Q were tested on harder-to-kill pathogens than Ebola.

How can TSG help?

Whether you’re looking to add an EVP claim to your product or need guidance on the necessary data requirements to make these claims possible, TSG’s regulatory team can help you. Questions? Get in touch with us: [email protected] 

Share via:

Contact us